Veradermics, Inc. (MANE)
100.91
-1.97
(-1.91%)
USD |
NYSE |
May 29, 16:00
100.20
-0.71
(-0.70%)
After-Hours: 20:00
Veradermics EPS Diluted (Quarterly) : -0.8037 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Organon & Co. | 0.5554 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.23M |
| Total Expenses (Quarterly) | 27.23M |
| Enterprise Value | 3.825B |
| Earnings Yield | -2.12% |
| Normalized Earnings Yield | -2.115 |